ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
36.26
+0.95 (2.69%)
May 16, 2025, 8:04 PM EDT
BIPIX Holdings List
As of Jan 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | SOCIETE' GENERALE C 4.2 , 2/03/2025 | 6.16% |
2 | n/a | HSBC SECURITIES (USA), INC. B 4.2 , 2/03/2025 | 5.69% |
3 | n/a | NATWEST MARKETS PLC M 4.2 , 2/03/2025 | 2.46% |
4 | NBIX | Neurocrine Biosciences, Inc. | 2.23% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.01% |
6 | NTRA | Natera, Inc. | 2.00% |
7 | ABBV | AbbVie Inc. | 1.99% |
8 | GILD | Gilead Sciences, Inc. | 1.98% |
9 | AMGN | Amgen Inc. | 1.97% |
10 | INSM | Insmed Incorporated | 1.95% |
11 | INCY | Incyte Corporation | 1.93% |
12 | n/a | ROYAL BANK OF CANADA 4.13 , 2/03/2025 | 1.90% |
13 | n/a | CREDIT AGRICOLE CIB NY A 4.2 , 2/03/2025 | 1.90% |
14 | VRTX | Vertex Pharmaceuticals Incorporated | 1.86% |
15 | PCVX | Vaxcyte, Inc. | 1.83% |
16 | UTHR | United Therapeutics Corporation | 1.83% |
17 | BMRN | BioMarin Pharmaceutical Inc. | 1.81% |
18 | MRNA | Moderna, Inc. | 1.74% |
19 | BIIB | Biogen Inc. | 1.72% |
20 | HALO | Halozyme Therapeutics, Inc. | 1.72% |
21 | SRPT | Sarepta Therapeutics, Inc. | 1.71% |
22 | EXAS | Exact Sciences Corporation | 1.67% |
23 | REGN | Regeneron Pharmaceuticals, Inc. | 1.64% |
24 | n/a | UMB FINANCIAL CORP. 4.08 , 2/03/2025 | 1.62% |
25 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 1.58% |
26 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.56% |
27 | TGTX | TG Therapeutics, Inc. | 1.48% |
28 | BPMC | Blueprint Medicines Corporation | 1.41% |
29 | VKTX | Viking Therapeutics, Inc. | 1.25% |
30 | BBIO | BridgeBio Pharma, Inc. | 1.20% |
31 | ADMA | ADMA Biologics, Inc. | 1.16% |
32 | CYTK | Cytokinetics, Incorporated | 1.15% |
33 | ROIV | Roivant Sciences Ltd. | 1.11% |
34 | IONS | Ionis Pharmaceuticals, Inc. | 1.06% |
35 | RVMD | Revolution Medicines, Inc. | 1.04% |
36 | EXEL | Exelixis, Inc. | 0.99% |
37 | APLS | Apellis Pharmaceuticals, Inc. | 0.98% |
38 | CRSP | CRISPR Therapeutics AG | 0.97% |
39 | SMMT | Summit Therapeutics Inc. | 0.94% |
40 | ALKS | Alkermes plc | 0.93% |
41 | RNA | Avidity Biosciences, Inc. | 0.82% |
42 | BHVN | Biohaven Ltd. | 0.73% |
43 | NUVL | Nuvalent, Inc. | 0.71% |
44 | TWST | Twist Bioscience Corporation | 0.69% |
45 | ACLX | Arcellx, Inc. | 0.68% |
46 | SWTX | SpringWorks Therapeutics, Inc. | 0.65% |
47 | RARE | Ultragenyx Pharmaceutical Inc. | 0.61% |
48 | KRYS | Krystal Biotech, Inc. | 0.61% |
49 | RXRX | Recursion Pharmaceuticals, Inc. | 0.61% |
50 | VCYT | Veracyte, Inc. | 0.58% |
51 | AKRO | Akero Therapeutics, Inc. | 0.55% |
52 | CLDX | Celldex Therapeutics, Inc. | 0.52% |
53 | TVTX | Travere Therapeutics, Inc. | 0.51% |
54 | PTGX | Protagonist Therapeutics, Inc. | 0.51% |
55 | PTCT | PTC Therapeutics, Inc. | 0.50% |
56 | GERN | Geron Corporation | 0.49% |
57 | VRDN | Viridian Therapeutics, Inc. | 0.47% |
58 | SLNO | Soleno Therapeutics, Inc. | 0.47% |
59 | DNLI | Denali Therapeutics Inc. | 0.46% |
60 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.46% |
61 | VERA | Vera Therapeutics, Inc. | 0.46% |
62 | DVAX | Dynavax Technologies Corporation | 0.46% |
63 | IOVA | Iovance Biotherapeutics, Inc. | 0.46% |
64 | FOLD | Amicus Therapeutics, Inc. | 0.45% |
65 | SRRK | Scholar Rock Holding Corporation | 0.44% |
66 | NVAX | Novavax, Inc. | 0.44% |
67 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.42% |
68 | BEAM | Beam Therapeutics Inc. | 0.40% |
69 | IDYA | IDEAYA Biosciences, Inc. | 0.40% |
70 | ARDX | Ardelyx, Inc. | 0.40% |
71 | ACAD | ACADIA Pharmaceuticals Inc. | 0.39% |
72 | CDNA | CareDx, Inc | 0.39% |
73 | ARQT | Arcutis Biotherapeutics, Inc. | 0.39% |
74 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.38% |
75 | CPRX | Catalyst Pharmaceuticals, Inc. | 0.37% |
76 | NTLA | Intellia Therapeutics, Inc. | 0.37% |
77 | PRAX | Praxis Precision Medicines, Inc. | 0.36% |
78 | IMVT | Immunovant, Inc. | 0.36% |
79 | SNDX | Syndax Pharmaceuticals, Inc. | 0.35% |
80 | VCEL | Vericel Corporation | 0.34% |
81 | AGIO | Agios Pharmaceuticals, Inc. | 0.34% |
82 | APGE | Apogee Therapeutics, Inc. | 0.34% |
83 | DYN | Dyne Therapeutics, Inc. | 0.33% |
84 | CGON | CG Oncology, Inc. | 0.33% |
85 | NRIX | Nurix Therapeutics, Inc. | 0.32% |
86 | JANX | Janux Therapeutics, Inc. | 0.32% |
87 | KYMR | Kymera Therapeutics, Inc. | 0.32% |
88 | MIRM | Mirum Pharmaceuticals, Inc. | 0.31% |
89 | MYGN | Myriad Genetics, Inc. | 0.30% |
90 | DAWN | Day One Biopharmaceuticals, Inc. | 0.28% |
91 | CAPR | Capricor Therapeutics, Inc. | 0.27% |
92 | IBRX | ImmunityBio, Inc. | 0.27% |
93 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.26% |
94 | SPRY | ARS Pharmaceuticals, Inc. | 0.26% |
95 | MNKD | MannKind Corporation | 0.25% |
96 | SYRE | Spyre Therapeutics, Inc. | 0.25% |
97 | GRAL | GRAIL, Inc. | 0.24% |
98 | RCKT | Rocket Pharmaceuticals, Inc. | 0.24% |
99 | EBS | Emergent BioSolutions Inc. | 0.23% |
100 | IRON | Disc Medicine, Inc. | 0.22% |
101 | COGT | Cogent Biosciences, Inc. | 0.21% |
102 | CDMO | Avid Bioservices, Inc. | 0.18% |
103 | ANAB | AnaptysBio, Inc. | 0.18% |
104 | VIR | Vir Biotechnology, Inc. | 0.18% |
105 | KURA | Kura Oncology, Inc. | 0.16% |
106 | RLAY | Relay Therapeutics, Inc. | 0.16% |
107 | PRTA | Prothena Corporation plc | 0.16% |
108 | REPL | Replimune Group, Inc. | 0.15% |
109 | HUMA | Humacyte, Inc. | 0.15% |
110 | ALT | Altimmune, Inc. | 0.15% |
111 | VERV | Verve Therapeutics, Inc. | 0.15% |
112 | SANA | Sana Biotechnology, Inc. | 0.14% |
113 | RCUS | Arcus Biosciences, Inc. | 0.14% |
114 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.14% |
115 | XNCR | Xencor, Inc. | 0.13% |
116 | CGEM | Cullinan Therapeutics, Inc. | 0.13% |
117 | IMNM | Immunome, Inc. | 0.13% |
118 | ETNB | 89bio, Inc. | 0.12% |
119 | ANNX | Annexon, Inc. | 0.12% |
120 | AVBP | ArriVent BioPharma, Inc. | 0.11% |
121 | STOK | Stoke Therapeutics, Inc. | 0.11% |
122 | RGNX | REGENXBIO Inc. | 0.11% |
123 | AVXL | Anavex Life Sciences Corp. | 0.10% |
124 | ALLO | Allogene Therapeutics, Inc. | 0.09% |
125 | DNTH | Dianthus Therapeutics, Inc. | 0.09% |
126 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.08% |
127 | ORIC | ORIC Pharmaceuticals, Inc. | 0.08% |
128 | KROS | Keros Therapeutics, Inc. | 0.07% |
129 | OLMA | Olema Pharmaceuticals, Inc. | 0.07% |
130 | ABUS | Arbutus Biopharma Corporation | 0.07% |
131 | KALV | KalVista Pharmaceuticals, Inc. | 0.07% |
132 | TRML | Tourmaline Bio, Inc. | 0.07% |
133 | LENZ | LENZ Therapeutics, Inc. | 0.06% |
134 | MDXG | MiMedx Group, Inc. | 0.06% |
135 | SGMO | Sangamo Therapeutics, Inc. | 0.06% |
136 | AKBA | Akebia Therapeutics, Inc. | 0.06% |
137 | SVRA | Savara Inc. | 0.06% |
138 | ERAS | Erasca, Inc. | 0.06% |
139 | TSHA | Taysha Gene Therapies, Inc. | 0.05% |
140 | CELC | Celcuity Inc. | 0.05% |
141 | ATXS | Astria Therapeutics, Inc. | 0.04% |
142 | YMAB | Y-mAbs Therapeutics, Inc. | 0.03% |
143 | GLUE | Monte Rosa Therapeutics, Inc. | 0.03% |
144 | CRGX | CARGO Therapeutics, Inc. | 0.02% |
145 | n/a | BIPIX_SPSIBI_GOLDMAN | -0.16% |
146 | n/a | BIPIX_SPSIBI_UB | -0.17% |
As of Jan 31, 2025